Does COVID-19-related viral sepsis stimulate angiotensin II levels more than bacterial sepsis?
dc.authorid | bicakcioglu, murat/0000-0001-9101-6857 | |
dc.authorwosid | bicakcioglu, murat/AAA-8149-2022 | |
dc.contributor.author | Demircan, Selcuk | |
dc.contributor.author | Bulut, Niluefer | |
dc.contributor.author | Kalkan, Serkan | |
dc.contributor.author | Duzenci, Deccane | |
dc.contributor.author | Bicakcioglu, Murat | |
dc.contributor.author | Ozden, Mehmet | |
dc.contributor.author | Dogan, Zafer | |
dc.date.accessioned | 2024-08-04T20:57:42Z | |
dc.date.available | 2024-08-04T20:57:42Z | |
dc.date.issued | 2023 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Aim: Angiotensin II and its receptors play a role in both COVID and bacterial sepsis. The aim of this study was to compare the levels of serum angiotensin II and its receptors in viral sepsis due to COVID-19 with the levels in bacterial sepsis.Material and Methods: The study included 62 sepsis patients (n=31 COVID and n=31 non-COVID) with similar disease severity in the tertiary ICU. The serum angiotensin II, angiotensin II receptors 1 and 2 (ATR1, ATR2) and other inflammatory parameters were measured. Demographic data and 28-day mortality were recorded.Results: Angiotensin II level was significantly higher in COVID patients than in non-COVID patients (p<0.05). ATR1 and ATR2 did not differ between the two groups. There was a negative correlation between angiotensin II and procalcitonin levels in all patients, and a positive correlation between ATR1 and procalcitonin, APACHE II score, and SOFA score in COVID patients (p<0.05).Discussion: Observation showed that angiotensin II levels were higher in patients with COVID-19 compared to those with bacterial sepsis, and ATR1 level was higher in COVID-19 patients who died. It was thought that the renin-angiotensin cascade could be stimulated differently in bacterial sepsis compared to viral sepsis due to COVID. | en_US |
dc.identifier.doi | 10.4328/ACAM.21713 | |
dc.identifier.endpage | 720 | en_US |
dc.identifier.issn | 2667-663X | |
dc.identifier.issue | 8 | en_US |
dc.identifier.startpage | 716 | en_US |
dc.identifier.uri | https://doi.org/10.4328/ACAM.21713 | |
dc.identifier.uri | https://hdl.handle.net/11616/102857 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wos | WOS:001050540900011 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bayrakol Medical Publisher | en_US |
dc.relation.ispartof | Annals of Clinical and Analytical Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Angiotensin II | en_US |
dc.subject | Bacterial Infection | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Sepsis | en_US |
dc.title | Does COVID-19-related viral sepsis stimulate angiotensin II levels more than bacterial sepsis? | en_US |
dc.type | Article | en_US |